Amedeo's Top 20

Amedeo Smart

Independent Medical Education

22 April 2024

Multidisciplinary Journal Club

  1. Vazquez MA, Oliver G, Amarasingham R, Sundaram V, et al.
    Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
    N Engl J Med 2024;390:1196-1206.

  1. Bergmark BA, Marston NA, Prohaska TA, Alexander VJ, et al.
    Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.
    N Engl J Med 2024.

  2. Blankenberg S, Seiffert M, Vonthein R, Baumgartner H, et al.
    Transcatheter or Surgical Treatment of Aortic-Valve Stenosis.
    N Engl J Med 2024.

  3. Meissner WG, Remy P, Giordana C, Maltete D, et al.
    Trial of Lixisenatide in Early Parkinson's Disease.
    N Engl J Med 2024;390:1176-1185.

  4. Shi Q, Wang Y, Hao Q, Vandvik PO, et al.
    Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials.
    Lancet 2024;403:e21-e31.

  1. Armandi A, Sanavia T, Younes R, Caviglia GP, et al.
    Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.
    Gut 2024;73:825-834.

  2. Geeratragool T, Kaosombatwattana U, Boonchote A, Chatthammanat S, et al.
    Comparison of Vonoprazan versus Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers Rebleeding after Successful Endoscopic Hemostasis: A Multicenter Randomized Noninferiority Trial.
    Gastroenterology 2024.

  3. Butler J, Shah SJ, Petrie MC, Borlaug BA, et al.
    Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
    Lancet 2024.

  4. de Boniface J, Filtenborg Tvedskov T, Ryden L, Szulkin R, et al.
    Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.
    N Engl J Med 2024;390:1163-1175.

  5. Wester A, Shang Y, Toresson Grip E, Matthews AA, et al.
    Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes.
    Gut 2024;73:835-843.

  1. Chandran M, Akesson KE, Javaid MK, Harvey N, et al.
    Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.
    Osteoporos Int 2024.

  2. Burnett-Bowie SM, Wright NC, Yu EW, Langsetmo L, et al.
    The American Society for Bone and Mineral Research Task Force on clinical algorithms for fracture risk report.
    J Bone Miner Res 2024.

  3. Moghe A, McGuire BM, Levy C.
    Acute hepatic porphyrias - a guide for Hepatologists.
    Hepatology 2024.

  4. St-Laurent MP, Acland G, Hamilton SN, Hamm J, et al.
    Long Term Second Malignancies in Prostate Cancer Patients Treated with Low-Dose-Rate Brachytherapy and Radical Prostatectomy.
    J Urol 2024.

  5. Qian H, Chi C, Tricard T, Zhu Y, et al.
    A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.
    J Urol 2024;211:648-655.

  1. Guo S, Li R, Li G, Chen W, et al.
    Comparing ChatGPT's and surgeon's responses to thyroid-related questions from patients.
    J Clin Endocrinol Metab 2024.

  2. Reina-Varona A, Madronero-Miguel B, Fierro-Marrero J, Paris-Alemany A, et al.
    Efficacy of various exercise interventions for migraine treatment: A systematic review and network meta-analysis.
    Headache 2024.

  3. Kamanda-Kosseh M, Shiau S, Agarwal S, Kondapalli A, et al.
    Bisphosphonates Maintain BMD after Sequential Teriparatide and Denosumab in Premenopausal Women with Idiopathic Osteoporosis.
    J Clin Endocrinol Metab 2024.

  4. Vignatelli L, Tontini V, Meletti S, Camerlingo M, et al.
    Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.
    Epilepsia 2024.

  5. Rieder F, Mukherjee PK, Massey WJ, Wang Y, et al.
    Fibrosis in IBD: from pathogenesis to therapeutic targets.
    Gut 2024;73:854-866.


Privacy Policy